同步荧光法同时测定苏丹红Ⅱ和苏丹红Ⅲ

开展了苏丹红的荧光分析研究, 为快速检测苏丹红提供了新的方法. 所建立的恒波长同步荧光法可同时对苏丹红Ⅱ和Ⅲ进行定性定量检测. 荧光方法具有很大的应用前景, 有望成为苏丹红的常规、快速、 简便的检测方法.     

Second derivative synchronous fluorescence spectroscopy for the simultaneous determination of metoclopramide and pyridoxine in syrup and human plasma

A rapid, simple, and highly sensitive second derivative synchronous fluorometric method has been developed for the simultaneous determination of metoclopramide (MT) and pyridoxine (PY) in a binary mixture. The method is based on measurement of the native fluorescence of these drugs at delta lambda = 80 nm in methanol. The different experimental parameters affecting the native fluorescence of the drugs were carefully studied and optimized. The fluorescence-concentration plots were rectilinear over the ranges of 0.02-0.4 and 0.1-2 microg/mL for MT and PY, respectively. The limits of detection were 0.003 and 0.007 microg/mL and the limits of quantification were 0.008 and 0.02 microg/mL for MT and PY, respectively. The proposed method was successfully applied to the determination of MT and PY in synthetic mixtures and in commercial syrup. The results were in good agreement with those obtained with a reported method. The high sensitivity attained by the proposed method allowed the determination of MT in spiked and real human plasma samples. The mean percent recoveries of MT from spiked and real human plasma (n = 3) were 93.72 +/- 3.15 and 89.72 +/- 2.19 respectively.     

Highly sensitive spectrophotometric methods for the determination, validation and thermogravimetric analysis of antiulcer drugs, nizatidine and ranitidine in pure and pharmaceutical preparations

Two sensitive, simple and rapid UV and second order derivative spectrophotometric methods were developed for the determination of nizatidine and ranitidine hydrochloride in pure form and pharmaceutical preparations. For the first method, UV spectrophotometic method, nizatidine was determined at 325 nm and ranitidine at 325.5 nm with detection limits of 0.07 and 0.04 μg/mL, respectively. For the second method, the distances between two extremum values (peak-to-peak amplitudes), 328/356.5 nm for nizatidine and 326/357 nm for ranitidine were measured in the second order derivative-spectra. The detection limits were found to be 0.02 μg/mL for nizatidine and 0.016 μg/mL for ranitidine, respectively. The thermal analysis of the two drugs was studied by Thermogravimetric Analysis-Differential Scanning Calorimetry (TGA-DSC) techniques. Enthalpy changes were obtained 121.9 and 124.15 J/g for nizatidine and ranitidine, respectively. The proposed method was successfully applied to the analysis of pharmaceutical preparations. The results were in good agreement with those obtained using the reference method; no significant difference were found in the accuracy and precision as revealed by the accepted values of t- and F-tests.     

蝶呤类化合物的荧光性能研究

研究了蝶呤类化合物的天然荧光特性。着重考察了新蝶呤、生物蝶呤、黄蝶呤和蝶呤在 p H7.7磷酸盐缓冲溶液条件下的荧光光谱及各种因素对其荧光强度的影响。在最佳实验条件下 ,四种蝶呤类化合物的线性范围为 :蝶呤 0 .6～ 2 .8μg/m L,新蝶呤 0～ 2 .6μg/m L,生物蝶呤 0～ 2 .4μg/m L,黄蝶呤 0～ 6.0 μg/m L,检出限依次为 :4.2 9× 1 0 - 7g/m L,6.71× 1 0 - 8g/m L,5.79× 1 0 - 9g/m L和 1 .75× 1 0 - 8g/m L     

Second-derivative synchronous fluorescence spectroscopy for the simultaneous determination of cinnarizine and nicergoline in pharmaceutical preparations

A rapid, simple, and highly sensitive second-derivative synchronous fluorometric method has been developed for the simultaneous analysis of binary mixtures of cinnarizine (CN) and nicergoline (NIC). The method is based upon measurement of the native fluorescence of these drugs at constant wavelength difference (Deltalambda) = 80 nm in aqueous methanol (50%, v/v). The different experimental parameters affecting the native fluorescence of the studied drugs were carefully studied and optimized. The fluorescence-concentration plots were rectilinear over the range of 0.025-1.5 and 0.25-5.5 microg/mL for CN and NIC, respectively, with lower detection limits of 0.58 and 0.82 ng/mL and quantitation limits of 1.93 and 2.73 ng/mL for CN and NIC, respectively. The proposed method was successfully applied for the determination of the studied compounds in synthetic mixtures and in commercial tablets. The results obtained were in good agreement with those obtained with reference methods. The high sensitivity attained by the proposed method allowed the determination of CN in real and spiked human plasma. The mean recovery in the case of spiked human plasma [number of trials (n) = 3] was 102.82 +/- 2.17%, while that in real human plasma (n = 3) was 105.25 +/- 2.05.     

磺胺嘧啶钠探针分析生物样品中蛋白质含量的研究

在pH 7.4的Tris-HCl缓冲溶液中,荧光猝灭光谱和三维荧光光谱显示磺胺嘧啶钠(SDS)可与人血清白蛋白(HSA)相互作用,使人血清白蛋白疏水微环境极性以及构象发生变化。考察了Δλ值、反应介质、离子强度等因素对该体系同步荧光光谱特征及强度的影响。在选定的最佳实验条件下,体系的同步荧光强度(ISF)与人血清白蛋白在1.38～276μg/mL的浓度范围内呈现良好的线性关系,线性相关系数为0.9992,从而建立了以磺胺嘧啶钠为分子探针,用固定波长同步荧光光谱分析测定蛋白质的新方法,检测限可达0.48μg/mL。用此方法对生物样品人血清、唾液和尿液中蛋白质含量进行了测定并进行加标回收实验,回收率在95.7%～103.7%之间。本文还用经典的考马斯亮蓝法对样品进行了测定,所得结果和本方法一致。同时还考察了一些常见的共存物质对蛋白质测定的影响。     

Determination of eprosartan mesylate and hydrochlorothiazide in tablets by derivative spectrophotometric and high-performance liquid chromatographic methods

Two new simple and selective assay methods have been presented for the analysis of eprosartan mesylate (EPR) and hydrochlorothiazide (HCT) in pharmaceutical formulations. The first method is based on first-derivative ultraviolet spectrophotometry with zero-crossing measurements at 246 and 279 nm for EPR and HCT, respectively. The assay was linear over the concentration ranges 3.0-14.0 μg/mL for EPR and 1.0-12.0 μg/mL for HCT. The quantification limits for EPR and HCT were found to be 1.148 and 0.581 μg/mL, respectively, while the detection limits were 0.344 μg/mL for EPR and 0.175 μg/mL for HCT. The second method involved isocratic reversed-phase liquid chromatography using a mobile phase composed of acetonitrile-10 mM phosphoric acid (pH 2.5) (40:60, v/v). Olmesartan was used as internal standard and the substances were detected at 272 nm. The linearity ranges were found to be 0.5-30 and 0.3-15.0 μg/mL for EPR and HCT, respectively. The limits of detection were found to be 0.121 μg/mL for EPR and 0.045 μg/mL for HCT. The limits of quantification were found to be 0.405 and 0.148 μg/mL for EPR and HCT, respectively. The proposed methods were successfully applied to the determination of commercially available tablets with a high percentage of recovery and good accuracy and precision.     

Kinetic Spectrophotometric Analysis and Spectrofluorimetric Analysis of Ciprofloxacin Hydrochloride and Norfloxacin in Pharmaceutical Preparations Using 4‐Chloro‐7‐Nitrobenzo‐2‐Oxa‐1,3‐Diazole (NBD‐Cl)

Simple, reliable, sensitive and accurate kinetic spectrophotometric and spectrofluorimetric methods were proposed for the determination of ciprofloxacin hydrochloride (CPX) and norfloxacin (NRX) in pure form and in pharmaceuticals. The methods are based on coupling the studied drugs with 4‐chloro‐7‐nitrobenzo‐2‐oxa‐1,3‐diazole (NBD‐Cl) in the presence of alkaline borate buffer. Spectrophotometric measurement was achieved by recording the absorbance at 477 nm after a fixed time of 20 and 15 min on a water bath adjusted at 70 ± 1 °C for CPX and NRX, respectively. The same product exhibited emission peaks at 540 nm. The different experimental parameters affecting the development and stability of the color were carefully studied and optimized. The absorbance concentration plots were linear over the ranges 3‐18 and 2.5‐15.0 μg/mL for CPX and NRX, respectively, while the fluorescence concentration plots were linear over the ranges 0.06‐0.36 and 0.05‐0.30 μg/mL for CPX and NRX, respectively. The limit of detection of the kinetic method was about 0.2 μg/mL for both drugs while the fluorescence measurement enabled their detection at a concentration of about 0.012 μg/mL. The proposed methods were successfully applied for the assay of the two drugs in their commercial products. The results obtained were statistically compared with those obtained by reference HPLC and spectrophotometric methods. The stoichiometry of the reaction was determined and the reaction pathway was postulated.     

Determination of ranitidine, nizatidine, and cimetidine by a sensitive fluorescent probe

A validated, simple, and sensitive fluorescence quenching method for the determination of ranitidine, nizatidine, and cimetidine in tablets and biological fluids is presented. This is the first single fluorescence method reported for the analysis of all three H(2) antagonists. The competitive reaction between the investigated drug and the palmatine probe for the occupancy of the cucurbit[7]uril (CB[7]) cavity was studied using spectrofluorometry. CB[7] was found to react with the probe to form a stable complex. The fluorescence intensity of the complex was also enhanced greatly. However, the addition of the drug dramatically quenched the fluorescence intensity of the complex. Accordingly, a new fluorescence quenching method for the determination of the studied drugs was established. The different experimental parameters affecting the fluorescence quenching intensity were studied carefully. At optimum reaction conditions, the rectilinear calibration graphs between the fluorescence quenching values (ΔF) and the medicament concentration were obtained in the concentration range of 0.04-1.9 μg mL(-1) for the investigated drugs. The limits of detection ranged from 0.013 to 0.030 μg mL(-1) at 495 nm using an excitation wavelength of 343 nm. The proposed method can be used for the determination of the three H(2) antagonists in raw materials, dosage forms and biological fluids.     

高效液相色谱-荧光分析法同时测定人体尿液中黄蝶呤与异黄蝶呤

建立了高效液相色谱-荧光法同时测定癌症病人尿液中黄蝶呤及异黄蝶呤的新方法。选择荧光检测波长λex=345nm,λem=420nm。以磷酸盐缓冲溶液(pH=7.5)-甲醇(体积比为98∶2)为流动相,流速1.0mL/min,黄蝶呤与异黄蝶呤含量分别在0.0013～0.945μg/mL及0.00017～0.118μg/mL范围内与色谱峰面积呈良好的线性关系,线性相关系数分别为0.9999和0.9996,检出限分别为0.5ng/mL和0.05ng/mL,加标平均回收率在86.2%～107.5%之间。方法应用于癌症病人尿样分析,取得了较好的结果。     

柱后还原-高效液相色谱法同时测定调制乳粉中维生素K1和维生素K2

建立了一种同时检测调制乳粉中维生素K₁和维生素K₂的柱后还原-高效液相色谱-荧光检测方法。样品用水溶解，经脂肪酶酶解，2.5 mol/L氢氧化钠溶液和乙醇溶液皂化，正己烷萃取，氮吹浓缩后，用甲醇复溶。通过Xbridge C₁₈色谱柱分离，锌粉还原柱柱后还原，荧光检测器检测，激发波长为326 nm，发射波长为432 nm，外标法定量。结果表明，维生素K₁在0.0025~2.0 μg/mL、维生素K₂在0.01~2.0 μg/mL范围内线性关系良好，相关系数均大于0.999，维生素K₁和维生素K₂的检出限分别为0.07 μg/100 g和0.24 μg/100 g，定量限分别为0.2 μg/100 g和0.8 μg/100 g；方法的加标回收率为80.39%~94.39%，精密度为0.85%~3.98%。该方法灵敏度高，重复性好，结果准确，适用于调制乳粉中维生素K₁和维生素K₂的分析检测。     

Derivative spectrophotometric analysis of benzophenone (as an impurity) in phenytoin

ABSTRACT: Three simple and rapid spectrophotometric methods were developed for detection and trace determination of benzophenone (the main impurity) in phenytoin bulk powder and pharmaceutical formulations. The first method, zero-crossing first derivative spectrophotometry, depends on measuring the first derivative trough values at 257.6 nm for benzophenone. The second method, zero-crossing third derivative spectrophotometry, depends on measuring the third derivative peak values at 263.2 nm. The third method, ratio first derivative spectrophotometry, depends on measuring the peak amplitudes of the first derivative of the ratio spectra (the spectra of benzophenone divided by the spectrum of 5.0 μg/mL phenytoin solution) at 272 nm. The calibration graphs were linear over the range of 1-10 μg/mL. The detection limits of the first and the third derivative methods were found to be 0.04 μg/mL and 0.11 μg/mL and the quantitation limits were 0.13 μg/mL and 0.34 μg/mL, respectively, while for the ratio derivative method, the detection limit was 0.06 μg/mL and the quantitation limit was 0.18 μg/mL. The proposed methods were applied successfully to the assay of the studied drug in phenytoin bulk powder and certain pharmaceutical preparations. The results were statistically compared to those obtained using a polarographic method and were found to be in good agreement.     

Capillary electrophoresis with LED-induced native fluorescence detection for determination of isoquinoline alkaloids and their cytotoxicity in extracts of Chelidonium majus L

In this study, we introduced a simple and sensitive method of capillary electrophoresis with ultraviolet light-emitting diode-induced native fluorescence (UV-LEDIF) detection for the determination of isoquinoline alkaloids in extracts of Chelidonium majus L. Samples were extracted with acidic methanol and the extracts were directly analysed by CE. Simultaneous determination of protopine, chelidonine, coptisine, sanguinarine, allocryptopine, chelerythrine and stylopine was performed in 20mM phosphate buffer (pH 3.1). The baseline separation of these alkaloids was finished within 20 min. As these alkaloids have native fluorescence, they were directly detected using the commercially available UV light emitting diode without troublesome fluorescent derivatisation. Satisfactory LOD values were obtained for the studied compounds considering their appearance in natural extracts. Lower limits of detection were 0.05 μg/mL for protopine, 0.06 μg/mL for stylopine and allocryptopine, 0.07 μg/mL for chelidonine, 0.22 μg/mL for sanguinarine, 1.7 μg/mL for chelerythrine and 5.5 μg/mL for coptisine. The developed method was successfully applied to determine the contents of seven alkaloids in the aerial parts of Chelidonium majus L, which varied from 0.025 to 0.763% (w/w). Also, to demonstrate the potential of the proposed CE method, an estimation of the cytotoxic properties of selected Celandine alkaloids in a natural extract was carried out.     

Simultaneous determination of 10 kinds of biogenic amines in rat plasma using high‐performance liquid chromatography coupled with fluorescence detection

We describe a simple, rapid, selective and sensitive HPLC method coupled with fluorescence detection for simultaneous determination of 10 kinds of biogenic amines (BAs: tryptamine, 2‐phenethylamine, putrescine, cadaverine, histamine, 5‐hydroxytryptamine, tyramine, spermidine, dopamine and spermine). BAs and IS were derivated with dansyl chloride. Fluorescence detection (λ_ex/λ_em = 340/510 nm) was used. A satisfactory result for method validation was obtained. The assay was shown to be linear over the ranges 0.005–1.0 μg/mL for tryptamine, 2‐phenethylamine and spermidine, 0.025–1.0 μg/mL for putrescine, 0.001–1.0 μg/mL for cadaverine, 0.25–20 μg/mL for histamine, 0.25–10 μg/mL for 5–hydroxytryptamine and dopamine, and 0.01–1.0 μg/mL for tyramine and spermine. The limits of detection and the limits of quantification were 0.3–75.0 ng/mL and 1.0–250.0 ng/mL, respectively. Relative standard deviations were ≤5.14% for intra‐day and ≤6.58% for inter‐day precision. The recoveries of BAs ranged from 79.11 to 114.26% after spiking standard solutions of BAs into a sample at three levels. Seven kinds of BAs were found in rat plasma, and the mean values of tryptamine, 2‐phenethylamine, putrescine, cadaverine, histamine, spermidine and spermine determined were 52.72 ± 7.34, 11.45 ± 1.56, 162.56 ± 6.26, 312.75 ± 18.11, 1306.50 ± 116.16, 273.89 ± 26.41 and 41.51 ± 2.07 ng/mL, respectively.     

Spectrophotometric determination of certain CNS stimulants in dosage forms and spiked human urine via derivatization with 2,4-Dinitrofluorobenzene

A new spectrophotometric method is developed for the determination of phenylpropanolamine HCl (PPA), ephedrine HCl (EPH) and pseudoephedrine HCl (PSE) in pharmaceutical preparations and spiked human urine. The method involved heat-catalyzed derivatization of the three drugs with 2,4-dinitrofluorobenzene (DNFB) producing a yellow colored product peaking at 370 nm for PPA and 380 nm for EPH and PSE, respectively. The absorbance concentration plots were rectilinear over the range of 2-20 for PPA and 1-14 μg/mL for both of EPH and PSE, respectively. The limit of detection (LOD) values were 0.20, 0.13 and 0.20 μg/mL for PPA, EPH and PSE, respectively and limit of quantitation (LOQ) values of 0.60 and 0.40 and 0.59 μg/mL for PPA, EPH and PSE, respectively. The analytical performance of the method was fully validated and the results were satisfactory. The proposed method was successfully applied to the determination of the three studied drugs in their commercial dosage forms including tablets, capsules and ampoules with good percentage recoveries. The proposed method was further applied for the determination of PSE in spiked human urine with a mean percentage recovery of 108.17 ± 1.60 for (n = 3). Statistical comparison of the results obtained with those of the comparison methods showed good agreement and proved that there was no significant difference in the accuracy and precision between the two methods. The mechanism of the reaction pathway was postulated.     

Cationic cyanine as a near-infrared fluorescent probe for the determination of nucleic acids

A new method with a cationic near-IR cyanine as fluorescent probe was developed for the determination of nucleic acids. The near-IR cyanine shows maximum excitation and emission wavelengths at 765 and 790 nm, respectively, in aqueous solution. The method is based on the fluorescence decrease of near-IR cyanine in the presence of nucleic acids. Under optimal conditions, the ratio of fluorescence intensity in the absence and presence of nucleic acids was proportional to the concentration of ¶nucleic acids over the range 0.10–1.2 μg/mL for CT (calf thymus) DNA or SM (salmon sperm) DNA, and 0.10–¶1.6 μg/mL for yeast RNA. The detection limits were ¶30 ng/mL for CT DNA, 25 ng/mL for SM DNA and ¶70 ng/mL for yeast RNA. The relative standard deviation (n = 6) was 2.1% for 500 ng/mL CT DNA, 2.4% for ¶500 ng/mL SM DNA and 2.7% for 500 ng/mL yeast RNA, respectively.     

High‐performance liquid chromatography with diode array detection method for the simultaneous determination of seven selected phosphodiesterase‐5 inhibitors and serotonin reuptake inhibitors used as male sexual enhancers

This work presents a simple, sensitive and generic high‐performance liquid chromatography with diode array detection method for the simultaneous determination of seven drugs prescribed for the treatment of erectile dysfunction and premature ejaculation. Investigated drugs include the phosphodiesterase‐5 inhibitors: sildenafil, tadalafil, and vardenafil, in addition to the selective serotonin reuptake inhibitors: dapoxetine, duloxetine, fluoxetine, and paroxetine. The drugs were separated using a Waters C8 column (4.6 × 250 mm, 5 μm) with the mobile phase consisting of phosphate buffer pH 3, acetonitrile and methanol in the ratio 60:33:7. The flow rate was 1.2 mL/min, and quantification was based on measuring peak areas at 225 nm. Peaks were perfectly resolved with retention times 3.3, 3.9, 6.4, 7.5, 9.5, 10.7, and 13.4 min for vardenafil, sildenafil, paroxetine, duloxetine, dapoxetine, fluoxetine, and tadalafil, respectively. The developed method was validated with respect to system suitability, linearity, ranges, accuracy, precision, robustness, and limits of detection and quantification. The proposed method showed good linearity in the ranges 5–500, 2–200, 2–200, 3–300, 1.5–150, 2–200, and 2–200 μg/mL for sildenafil, tadalafil, vardenafil, dapoxetine, duloxetine fluoxetine, and paroxetine, respectively. The limits of detection were 0.18–0.38 μg/mL for the analyzed compounds. The applicability of the proposed method to real life situations was assessed through the analysis of commercial tablets, and satisfactory results were obtained.     

快速测定生物样品中蛋白含量的同步荧光法研究

最佳实验条件下,基于脱氧尿苷与人血清白蛋白(HSA)相互作用,导致血清白蛋白的同步荧光光谱发生特异性变化,且体系的同步荧光强度和溶液中白蛋白的浓度呈良好的线性关系,建立了以脱氧尿苷为探针,运用固定波长同步荧光光谱快速测定生物样品中蛋白质总含量的新方法.深入考察了△λ值、反应介质、试剂用量、离子强度、加入顺序、反应时间等因素对测定的影响.在最佳实验条件下,体系的同步荧光强度与血清白蛋白在2.76～524.4μg/mL范围内的线性相关系数为0.9991,方法的检出限可达0.11μg/mL.运用本方法对人血清、唾液和尿液等生物样品进行测定并进行加标回收实验,回收率在98.0%～102.5%之间.对11份空白溶液进行平行测定,相对标准差为1.2%.用经典的考马斯亮蓝G-250(CBB)法做了对照实验,两种方法测定结果基本一致.还考察了一些常见离子和有机物存在时对蛋白质测定的影响.本方法已用于血清、唾液和尿样等生物样品中蛋白质总量的快速测定.     

RP-HPLC method for simultaneous estimation of lamivudine, tenofovir disoproxil fumarate and efavirenz in tablet formulation

A simple, rapid, and precise reversed-phase high-performance liquid chromatographic method for the simultaneous determination of lamivudine, tenofovir disoproxil fumarate and efavirenz in bulk and tablet dosage form has been developed and validated. Chromatography was performed on a 150 mm × 4.6 mm i.d., 5-μm particle, Phenomenex Luna C₁₈ column with 30: 45: 25 (v/v/v) acetonitrile: methanol: water as mobile phase at a flow rate of 0.5 mL/min. UV detection was done at 258 nm; lamivudine, tenofovir disoproxil fumarate and efavirenz were eluted with retention times of 3.27, 4.58 and 10.90 min, respectively. The method was validated in accordance with ICH guidelines. Validation revealed the method is specific, rapid, accurate, precise, reliable and reproducible. Calibration plots were linear over the concentration ranges 1–6 μg/mL for lamivudine and tenofovir disoproxil fumarate and 2–12 μg/mL for efavirenz. Limits of detection were 0.05, 0.09 and 0.11 μg/mL and limits of quantification were 0.15, 0.28 and 0.34 μg/mL for lamivudine, tenofovir disoproxil fumarate and efavirenz, respectively. The high recovery and low coefficients of variation confirm the suitability of the method for the simultaneous determination of these three drugs in bulk and tablets.     

Application of magdala red as a fluorescence probe in the determination of nucleic acids

A fluorescence quenching method was developed for the rapid determination of DNA and RNA using magdala red as fluorescence probe. In weakly acidic ¶medium, the fluorescence of magdala red (λex>lem = 54055 nm) can be largely quenched by DNA or RNA. The calibration graphs are linear over the range 0.01–¶1.2 μg/mL for both calf thymus DNA (CT DNA) and salmon DNA (SM DNA), and 0.015–1.0 μg/mL for yeast RNA, respectively. The corresponding detection limits are ¶6.0 ng/mL for CT DNA, 7.0 ng/mL for SM DNA and ¶15.0 ng/mL for yeast RNA, respectively. CT DNA could be determined in the presence of 20% (w/w) yeast RNA, and the relative standard deviation of six replicate measurements is 3.18% for 400 ng/mL of CT DNA. Interference from coexisting substances in the determination of DNA was also examined. Real samples were determined with satisfactory results.